Showing results (331-340 of 340) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 340 results.
American Journal of Epidemiology|August 1, 1979
Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977L B Schonberger, D J Bregman, J Z Sullivan-Bolyai, et al.
The American Surgeon|January 1, 1995
First place winner of the Conrad Jobst Award in the gold medal paper competition. Nitric oxide synthase inhibitors N-monomethylarginine and aminoguanidine prevent the progressive and severe hypotension associated with a rat model of pancreatitisT J Lomis, C W Siffring, S Chalasani, et al.
Journal of Virology|August 1, 1990
Infection of the human monocytic cell line Mono Mac6 with human immunodeficiency virus types 1 and 2 results in long-term production of virus variants with increased cytopathogenicity for CD4+ T cellsJ L'age-Stehr, M Niedrig, H R Gelderblom, et al.
Physical Review Letters|September 3, 2013
Observation of gigawatt-class THz pulses from a compact laser-driven particle acceleratorA Gopal, S Herzer, A Schmidt, et al.
Tree Physiology|January 1, 1996
Environmental regulation of xylem sap flow and total conductance of Larix gmelinii trees in eastern SiberiaA. Arneth, F. M. Kelliher, G. Bauer, et al.
Molecular Medicine (Cambridge, Mass.)|February 5, 1999
Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritisE L Kaijzel, M V van Krugten, B M Brinkman, et al.
Mayo Clinic Proceedings|February 13, 2007
Seroprevalence of antibody to varicella among Somali refugeesLana J Nysse, Norman A Pinsky, Jeffrey P Bratberg, et al.
Oecologia|March 18, 2017
Above-ground biomass and structure of pristine Siberian Scots pine forests as controlled by competition and fireC Wirth, E-D Schulze, W Schulze, et al.
The American Journal of Medicine|May 12, 2024
The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVIDHarlan M Krumholz, Mitsuaki Sawano, Bornali Bhattacharjee, et al.
The Lancet. Infectious Diseases|April 6, 2025
Nirmatrelvir-ritonavir versus placebo-ritonavir in individuals with long COVID in the USA (PAX LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trialMitsuaki Sawano, Bornali Bhattacharjee, César Caraballo, et al.
Pageof 34